BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32133717)

  • 1. Empirical assessment of case-based methods for drug safety alert identification in the French National Healthcare System database (SNDS): Methodology of the ALCAPONE project.
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):993-1000. PubMed ID: 32133717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical assessment of case-based methods for identification of drugs associated with upper gastrointestinal bleeding in the French National Healthcare System database (SNDS).
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2020 Aug; 29(8):890-903. PubMed ID: 32524701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Empirical assessment of case-based methods for identification of drugs associated with acute liver injury in the French National Healthcare System database (SNDS).
    Thurin NH; Lassalle R; Schuemie M; Pénichon M; Gagne JJ; Rassen JA; Benichou J; Weill A; Blin P; Moore N; Droz-Perroteau C
    Pharmacoepidemiol Drug Saf; 2021 Mar; 30(3):320-333. PubMed ID: 33099844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases.
    Coloma PM; Avillach P; Salvo F; Schuemie MJ; Ferrajolo C; Pariente A; Fourrier-Réglat A; Molokhia M; Patadia V; van der Lei J; Sturkenboom M; Trifirò G
    Drug Saf; 2013 Jan; 36(1):13-23. PubMed ID: 23315292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of a health insurance database to conduct pharmacoepidemiological studies in oncology.
    Conte C; Vaysse C; Bosco P; Noize P; Fourrier-Reglat A; Despas F; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):279-288. PubMed ID: 30824175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection.
    Trifirò G; Patadia V; Schuemie MJ; Coloma PM; Gini R; Herings R; Hippisley-Cox J; Mazzaglia G; Giaquinto C; Scotti L; Pedersen L; Avillach P; Sturkenboom MC; van der Lei J; Eu-Adr Group
    Stud Health Technol Inform; 2011; 166():25-30. PubMed ID: 21685607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network.
    Ferrajolo C; Coloma PM; Verhamme KM; Schuemie MJ; de Bie S; Gini R; Herings R; Mazzaglia G; Picelli G; Giaquinto C; Scotti L; Avillach P; Pedersen L; Rossi F; Capuano A; van der Lei J; Trifiró G; Sturkenboom MC;
    Drug Saf; 2014 Feb; 37(2):99-108. PubMed ID: 24446276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacovigilance systems and databases in Korea, Japan, and Taiwan.
    Kimura T; Matsushita Y; Yang YH; Choi NK; Park BJ
    Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1237-45. PubMed ID: 21936017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
    Welch HK; Kellum JA; Kane-Gill SL
    Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug related falls: a study in the French Pharmacovigilance database.
    Souchet E; Lapeyre-Mestre M; Montastruc JL
    Pharmacoepidemiol Drug Saf; 2005 Jan; 14(1):11-6. PubMed ID: 15508129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients.
    Tomlin AM; Reith DM; Woods DJ; Lloyd HS; Smith A; Fountain JS; Tilyard MW
    Drug Saf; 2017 Dec; 40(12):1259-1277. PubMed ID: 28766108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Useful Interplay Between Spontaneous ADR Reports and Electronic Healthcare Records in Signal Detection.
    Pacurariu AC; Straus SM; Trifirò G; Schuemie MJ; Gini R; Herings R; Mazzaglia G; Picelli G; Scotti L; Pedersen L; Arlett P; van der Lei J; Sturkenboom MC; Coloma PM
    Drug Saf; 2015 Dec; 38(12):1201-10. PubMed ID: 26370104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nordic prescription databases as a resource for pharmacoepidemiological research--a literature review.
    Wettermark B; Zoëga H; Furu K; Korhonen M; Hallas J; Nørgaard M; Almarsdottir A; Andersen M; Andersson Sundell K; Bergman U; Helin-Salmivaara A; Hoffmann M; Kieler H; Martikainen J; Mortensen M; Petzold M; Wallach-Kildemoes H; Wallin C; Sørensen H
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):691-9. PubMed ID: 23703712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining a reference set to support methodological research in drug safety.
    Ryan PB; Schuemie MJ; Welebob E; Duke J; Valentine S; Hartzema AG
    Drug Saf; 2013 Oct; 36 Suppl 1():S33-47. PubMed ID: 24166222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The drugs that mostly frequently induce acute kidney injury: a case - noncase study of a pharmacovigilance database.
    Pierson-Marchandise M; Gras V; Moragny J; Micallef J; Gaboriau L; Picard S; Choukroun G; Masmoudi K; Liabeuf S;
    Br J Clin Pharmacol; 2017 Jun; 83(6):1341-1349. PubMed ID: 28002877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prediction model-based algorithm for computer-assisted database screening of adverse drug reactions in the Netherlands.
    Scholl JHG; van Hunsel FPAM; Hak E; van Puijenbroek EP
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):199-205. PubMed ID: 29271017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication of the OMOP experiment in Europe: evaluating methods for risk identification in electronic health record databases.
    Schuemie MJ; Gini R; Coloma PM; Straatman H; Herings RM; Pedersen L; Innocenti F; Mazzaglia G; Picelli G; van der Lei J; Sturkenboom MC
    Drug Saf; 2013 Oct; 36 Suppl 1():S159-69. PubMed ID: 24166232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.
    Leone R; Conforti A; Venegoni M; Motola D; Moretti U; Meneghelli I; Cocci A; Sangiorgi Cellini G; Scotto S; Montanaro N; Velo G
    Drug Saf; 2005; 28(6):547-56. PubMed ID: 15924506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More on the "Triple Whammy": antihypertensive drugs, non-steroidal anti-inflammatory agents and acute kidney injury - a case/non-case study in the French pharmacovigilance database.
    Fournier JP; Sommet A; Durrieu G; Poutrain JC; Lapeyre-Mestre M; Montastruc JL;
    Ren Fail; 2014 Aug; 36(7):1166-8. PubMed ID: 24826803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.